MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/inf.0000000000003297

Медицинская библиотека · The Pediatric infectious disease journal · 2021

Safety and Experience With Combined Antiretroviral Prophylaxis in Newborn at High-risk of Perinatal HIV Infection, in a Cohort of Mother Living With HIV-infant Pairs.

Illán Ramos Marta, Soto Sánchez Beatriz, Mazariegos Orellana Diana, Prieto Tato Luis Manuel, Guillén Martín Sara, Navarro Gómez Mª Luisa, Del Rosal Rabes Teresa, Escosa García Luis, Roa Francia Miguel Ángel, Beceiro Mosquera José, Olabarrieta Arnal Iciar, Muñoz Gálligo Eloy, Viñuela Beneitez Mª Carmen, Regidor Sáez Francisco Javier, Serrano García Irene, Berzosa Sánchez Arantxa, Callejas Caballero Ignacio, Ramos Amador José Tomás, Madrid Cohort of HIV-infected Mother-infant pairs

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Perinatal transmission of HIV has dramatically decreased in high-income countries in the last few years with current rates below 1%, but it still occurs in high-risk situations, mainly pregnant women with late diagnosis of infection, poor antiretroviral adherence and a high viral load (VL). In these high-risk situations, many providers recommend combined neonatal prophylaxis (CNP). Our aim was to evaluate the safety and toxicity of CNP in infants deemed at high-risk of HIV infection among mother-infant pairs in the Madrid Cohort.

MATERIALS AND

METHODS

Prospective, multicenter, observational cohort study between years 2000 and 2019. The subgroup of newborns on CNP and their mothers were retrospectively selected (cohort A) and compared with those who received monotherapy with zidovudine (cohort B). Infants with monotherapy were classified according to treatment regimes in long (6 weeks) and short (4 weeks) course.

RESULTS

We identified 227 newborns (33.3% preterm and 7 sets of twins) with CNP. A maternal diagnosis of HIV-1 infection was established during the current pregnancy in 72 cases (36.4%) and intrapartum or postpartum in 31 cases (15.7%). Most infants received triple combination antiretroviral therapy (65.6%; n = 149). The perinatal transmission rate in cohort A was 3.5% (95% confidence interval: 1.13%-5.92%). Infants from cohort A developed anemia (26.1% vs. 19.4%, P = 0.14) and neutropenia more frequently at 50-120 days (21.4% vs. 10.9%, P < 0.01), without significant differences in grade 3 and 4 anemia or neutropenia between the two cohorts. There were no differences in increased alanine aminotransferase. Neutropenia was more common in the long zidovudine regimes.

CONCLUSIONS

Our findings provide further evidence of the safety of CNP in infants with high-risk of HIV-1 perinatal transmission.

Для цитирования: Illán Ramos Marta, Soto Sánchez Beatriz, Mazariegos Orellana Diana, Prieto Tato Luis Manuel, Guillén Martín Sara, Navarro Gómez Mª Luisa, Del Rosal Rabes Teresa, Escosa García Luis, Roa Francia Miguel Ángel, Beceiro Mosquera José, Olabarrieta Arnal Iciar, Muñoz Gálligo Eloy, Viñuela Beneitez Mª Carmen, Regidor Sáez Francisco Javier, Serrano García Irene, Berzosa Sánchez Arantxa, Callejas Caballero Ignacio, Ramos Amador José Tomás, Madrid Cohort of HIV-infected Mother-infant pairs. Safety and Experience With Combined Antiretroviral Prophylaxis in Newborn at High-risk of Perinatal HIV Infection, in a Cohort of Mother Living With HIV-infant Pairs.. The Pediatric infectious disease journal. 2021. DOI: 10.1097/inf.0000000000003297.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.